Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

More active high-dose chemotherapy (HDC) regimens are needed for refractory Hodgkin's lymphoma (HL). We report a cohort analysis of 180 consecutive patients with primary refractory or poor-risk relapsed HL treated with busulfan-melphalan (Bu-Mel) (n = 39), gemcitabine-busulfan-melphalan (Gem-Bu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nieto, Yago, Popat, Uday, Anderlini, Paolo, Valdez, Ben, Andersson, Borje, Liu, Ping, Hosing, Chitra, Shpall, Elizabeth J., Alousi, Amin, Kebriaei, Partow, Qazilbash, Muzaffar, Parmar, Simrit, Bashir, Qaiser, Shah, Nina, Khouri, Issa, Rondon, Gabriela, Champlin, Richard, Jones, Roy B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077191/
https://ncbi.nlm.nih.gov/pubmed/23128322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.10.029
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi